Literature DB >> 19922554

Relationships between auditory event-related potentials and mood state, medication, and comorbid psychiatric illness in patients with bipolar disorder.

Daniel J Fridberg1, William P Hetrick, Colleen A Brenner, Anantha Shekhar, Ashley N Steffen, Frederick W Malloy, Brian F O'Donnell.   

Abstract

BACKGROUND: Patients with bipolar disorder (BD) exhibit aberrations in auditory event-related potentials (ERPs), although the relationships between these measures and mood state at testing, comorbid psychiatric illness, presence of psychotic features, and medication usage are unclear. The purpose of this study was to investigate the relationships between these factors and auditory ERP measures in BD patients.
METHODS: An auditory 'oddball' discrimination task was used to elicit ERPs from 69 patients with type I BD and 52 healthy controls. Patients were placed into subgroups based upon their mood state at testing (euthymic or symptomatic), and ANOVA was used to compare amplitude and peak latency measures from the N100, P200, N200, and P300 ERP components across subgroups. Multiple regression was used to investigate relationships between ERP measures and comorbid psychiatric diagnosis, history of psychotic features, and medication status.
RESULTS: Relative to healthy control participants, euthymic and symptomatic BD patients exhibited reduced P300 and P200 amplitude, but ERP measures did not differ among BD patients on the basis of mood status. A history of a comorbid anxiety disorder was associated with reduced N200 peak latency, but prolonged P300 peak latency among BD patients. No other relationships between clinical variables and ERP measures were significant.
CONCLUSIONS: The results suggest that disrupted auditory attention may be observed in BD patients regardless of their mood state at testing, medication status, or history of psychosis. These results extend previous findings, and provide further evidence for aberrations in the P300 ERP as an endophenotype for BD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19922554      PMCID: PMC4655591          DOI: 10.1111/j.1399-5618.2009.00758.x

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  44 in total

Review 1.  Neuropsychology and neuropharmacology of P3a and P3b.

Authors:  John Polich; José R Criado
Journal:  Int J Psychophysiol       Date:  2006-02-28       Impact factor: 2.997

2.  Auditory event-related potentials in panic disorder.

Authors:  A Iwanami; H Isono; Y Okajima; K Kamijima
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1997       Impact factor: 5.270

3.  Montgomery-Asberg severity gradations.

Authors:  N Mittmann; S Mitter; E K Borden; N Herrmann; C A Naranjo; N H Shear
Journal:  Am J Psychiatry       Date:  1997-09       Impact factor: 18.112

4.  A new method for off-line removal of ocular artifact.

Authors:  G Gratton; M G Coles; E Donchin
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1983-04

5.  A metric for thought: a comparison of P300 latency and reaction time.

Authors:  G McCarthy; E Donchin
Journal:  Science       Date:  1981-01-02       Impact factor: 47.728

6.  CNS recovery from cocaine, cocaine and alcohol, or opioid dependence: a P300 study.

Authors:  L O Bauer
Journal:  Clin Neurophysiol       Date:  2001-08       Impact factor: 3.708

7.  Auditory event-related potentials in panic and generalised anxiety disorders.

Authors:  Tayfun Turan; Ertugrul Esel; Fatih Karaaslan; Mustafa Basturk; Aslan Oguz; Ihsan Yabanoglu
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2002-01       Impact factor: 5.067

Review 8.  Endophenotypes in the genetic analyses of mental disorders.

Authors:  Tyrone D Cannon; Matthew C Keller
Journal:  Annu Rev Clin Psychol       Date:  2006       Impact factor: 18.561

9.  Distinct neurophysiological mechanisms for manic and cycloid psychoses: evidence from a P300 study on manic patients.

Authors:  W K Strik; M Ruchsow; S Abele; A J Fallgatter; T J Mueller
Journal:  Acta Psychiatr Scand       Date:  1998-12       Impact factor: 6.392

10.  Residual symptoms in bipolar disorder: the effect of the last episode after remission.

Authors:  Ender Kaya; Omer Aydemir; Deniz Selcuki
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2007-06-14       Impact factor: 5.067

View more
  11 in total

1.  Event-related potential and time-frequency endophenotypes for schizophrenia and psychotic bipolar disorder.

Authors:  Lauren E Ethridge; Jordan P Hamm; Godfrey D Pearlson; Carol A Tamminga; John A Sweeney; Matcheri S Keshavan; Brett A Clementz
Journal:  Biol Psychiatry       Date:  2014-05-04       Impact factor: 13.382

2.  Decrease of theta response in euthymic bipolar patients during an oddball paradigm.

Authors:  M İ Atagün; B Güntekin; A Ozerdem; E Tülay; E Başar
Journal:  Cogn Neurodyn       Date:  2012-12-09       Impact factor: 5.082

Review 3.  Sustained attention in psychosis: Neuroimaging findings.

Authors:  Gianna Sepede; Maria Chiara Spano; Marco Lorusso; Domenico De Berardis; Rosa Maria Salerno; Massimo Di Giannantonio; Francesco Gambi
Journal:  World J Radiol       Date:  2014-06-28

4.  Family history of psychosis moderates early auditory cortical response abnormalities in non-psychotic bipolar disorder.

Authors:  Jordan P Hamm; Lauren E Ethridge; John R Shapiro; Godfrey D Pearlson; Carol A Tamminga; John A Sweeney; Matcheri S Keshavan; Gunvant K Thaker; Brett A Clementz
Journal:  Bipolar Disord       Date:  2013-08-14       Impact factor: 6.744

5.  Reduced electroencephalogram responses to standard and target auditory stimuli in bipolar disorder and the impact of psychotic features: Analysis of event-related potentials, spectral power, and inter-trial coherence.

Authors:  Nancy B Lundin; Lisa A Bartolomeo; Brian F O'Donnell; William P Hetrick
Journal:  Bipolar Disord       Date:  2017-10-11       Impact factor: 6.744

6.  Neural activations during auditory oddball processing discriminating schizophrenia and psychotic bipolar disorder.

Authors:  Lauren E Ethridge; Jordan P Hamm; John R Shapiro; Ann T Summerfelt; Sarah K Keedy; Michael C Stevens; Godfrey Pearlson; Carol A Tamminga; Nash N Boutros; John A Sweeney; Matcheri S Keshavan; Gunvant Thaker; Brett A Clementz
Journal:  Biol Psychiatry       Date:  2012-05-08       Impact factor: 13.382

7.  Special Report on the Impact of the COVID-19 Pandemic on Clinical EEG and Research and Consensus Recommendations for the Safe Use of EEG.

Authors:  Salvatore Campanella; Kemal Arikan; Claudio Babiloni; Michela Balconi; Maurizio Bertollo; Viviana Betti; Luigi Bianchi; Martin Brunovsky; Carla Buttinelli; Silvia Comani; Giorgio Di Lorenzo; Daniel Dumalin; Carles Escera; Andreas Fallgatter; Derek Fisher; Giulia Maria Giordano; Bahar Guntekin; Claudio Imperatori; Ryouhei Ishii; Hendrik Kajosch; Michael Kiang; Eduardo López-Caneda; Pascal Missonnier; Armida Mucci; Sebastian Olbrich; Georges Otte; Andrea Perrottelli; Alessandra Pizzuti; Diego Pinal; Dean Salisbury; Yingying Tang; Paolo Tisei; Jijun Wang; Istvan Winkler; Jiajin Yuan; Oliver Pogarell
Journal:  Clin EEG Neurosci       Date:  2020-09-25       Impact factor: 1.843

8.  Altered visual information processing systems in bipolar disorder: evidence from visual MMN and P3.

Authors:  Toshihiko Maekawa; Satomi Katsuki; Junji Kishimoto; Toshiaki Onitsuka; Katsuya Ogata; Takao Yamasaki; Takefumi Ueno; Shozo Tobimatsu; Shigenobu Kanba
Journal:  Front Hum Neurosci       Date:  2013-07-26       Impact factor: 3.169

9.  Absence of auditory M100 source asymmetry in schizophrenia and bipolar disorder: a MEG study.

Authors:  Ying Wang; Yigang Feng; Yanbin Jia; Yanping Xie; Wensheng Wang; Yufang Guan; Shuming Zhong; Dan Zhu; Li Huang
Journal:  PLoS One       Date:  2013-12-10       Impact factor: 3.240

10.  Shared and Disorder-Specific Event-Related Brain Oscillatory Markers of Attentional Dysfunction in ADHD and Bipolar Disorder.

Authors:  Giorgia Michelini; Viryanaga Kitsune; Isabella Vainieri; Georgina M Hosang; Daniel Brandeis; Philip Asherson; Jonna Kuntsi
Journal:  Brain Topogr       Date:  2018-02-07       Impact factor: 3.020

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.